04:38 PM EDT, 06/06/2025 (MT Newswires) -- Rakovina Therapeutics ( RKVTF ) after close of trade Friday closed a non-brokered private placement of share units and convertible debentures that raised $4.91 million.

The company raised $3.56 million from the sale of units made up of a share and a two-year warrant to buy a second share for $0.10.

It also placed $1.35 million of debenture units, made up a $50,000 three-year, 12% debenture that can be converting into shares priced and $0.10 and 100,000 two-year warrant to buy a share for $0.15.

Each warrant entitles the holder to purchase one additional common share at a price of $0.10.

Proceeds "are intended to support Rakovina Therapeutics' ( RKVTF ) growth across multiple fronts, including the continued integration of its proprietary next-generation AI-driven drug discovery tools, and the efforts to expand visibility among institutional investors in U.S. and global capital markets", the company said

The company's shares closed unchanged at $0.05 on the TSX Venture Exchange.